[Topic] Immunotherapy in treatment of locally advanced SCCHN - current paradigms and unmet needs

[Date] 24 April 2026 

[Opening Remarks] 0:00:00~

Opening Remarks and Introduction of ATLAS

Speaker: Dr. Mitsumi Terada

(Head, Asian Partnerships Section, Department of International Clinical Development, National Cancer Center Hospital, Japan)

[Lecture 1] 0:05:41~

Perioperative immunotherapy in head and neck cancer – hope or hype

Speaker: Dr. Gopal Iyerw

（National Cancer Centre, Singapore)

[Lecture 2] 0:23:44~

Current Status and Future Directions of Combination Therapy in HNSCC

: Strategic Optimization in Locally-Advanced and Recurrent or Metastatic Disease 

Speaker: Dr. Kao Hsiang Fong

(National Taiwan University Hospital, Taiwan)

[Discussion] 0:42:11~

Discussion

Facilitator: Dr. Mitsumi Terada

(Head, Asian Partnerships Section, Department of International Clinical Development, National Cancer Center Hospital, Japan)